PCOS vs PCOD: What's the Difference? An Indian Doctor's Guide

If you have spent any time in an Indian gynaecologist's waiting room, on a family WhatsApp group, or scrolling reels about irregular periods, you have almost certainly heard both terms — PCOD and PCOS — used as if they are different things. One aunt says she has "PCOD." A cousin was diagnosed with "PCOS." A reel insists PCOD is "just a lifestyle problem" while PCOS is "a serious disease." No wonder so many Indian women are confused and a little frightened.

So let us settle it clearly, the way I would in a consultation. Are PCOD and PCOS the same condition? What does the science actually say? And — most importantly — what does the answer mean for your body, your cycle, and your choices?

The short answer

For practical purposes, PCOD and PCOS describe the same underlying condition. In everyday Indian usage — and even among many clinicians — the two terms are used interchangeably for a hormonal and metabolic disorder in which the ovaries, hormones, and metabolism stop working in sync.

The real difference is one of language and precision, not biology:

• PCOD stands for Polycystic Ovarian Disease — an older, descriptive term that focuses on how the ovaries look (many small follicles, often loosely called "cysts").
• PCOS stands for Polycystic Ovary Syndrome — the term used in international medical guidelines, because the condition is a syndrome: a cluster of features spanning hormones, ovulation, and metabolism, not merely an ovarian "disease."

Put simply: "PCOD" describes what the ovaries look like, while "PCOS" describes the whole system that is actually involved. The medically accurate term today is PCOS — and, as you will see, even that name is now evolving.

Why two names exist (and where "PMOS" fits in)

Medicine renames conditions as understanding deepens. For decades, doctors saw enlarged ovaries dotted with small follicles on ultrasound and called it "polycystic ovarian disease." But two decades of research made one thing clear: the ovaries are not the root cause — they are the messenger. The real drivers sit upstream, in the body's hormonal and metabolic signalling.

That is why the global medical community moved to "polycystic ovary syndrome." And it is why, at Qura, you will increasingly see us use a newer term — PMOS — which is designed to put the metabolic and whole-endocrine nature of the condition front and centre, rather than the ovaries alone. If that term is new to you, we have written a plain-language explainer on understanding PMOS and what the shift in name means for you.

The takeaway: PCOD, PCOS, and PMOS are not three different diseases. They are three names — old, current, and emerging — for one complex, whole-body condition.

The biggest myth: "PCOD is mild, PCOS is severe"

This is the single most common misconception I correct in clinic, and it deserves to be said plainly:

There is no evidence-based rule that "PCOD" is the mild version and "PCOS" is the severe one. They are the same diagnosis. How serious it is depends on your individual pattern — not on which of the two words your doctor happened to use.

What genuinely does vary is the phenotype — the specific combination of features a woman has. Based on research indexed on PubMed, the internationally used Rotterdam criteria produce four recognised PCOS phenotypes, ranging from women with all three core features to those with only two (Lizneva et al., Fertility and Sterility, 2016). One woman may have severe cycle irregularity but few metabolic problems; another may have only mild cycle changes but significant insulin resistance. Both have "PCOS/PCOD." Their day-to-day experience — and their ideal treatment — can look very different.

So the useful question is never "Do I have PCOD or PCOS?" It is: "Which phenotype do I have, and what is driving it?"

What is actually happening inside your body

Whatever you call it, the underlying biology is a self-reinforcing loop involving three systems:

• Hormones. Many women with PCOS have higher-than-typical levels of androgens (often called "male" hormones, although every woman makes them). This is what tends to drive acne, unwanted facial or body hair (hirsutism), and scalp hair thinning.
• Ovulation. Raised androgens and disrupted signalling interfere with the monthly release of an egg. Cycles become long, unpredictable, or absent — which is why missed periods are such a common complaint.
• Metabolism — especially insulin. This is the piece most often missed. According to a 2023 review in the Journal of Ovarian Research, insulin resistance is "a major cause" of PCOS and is found across phenotypes, in both higher-weight and lean women (Zhao et al., 2023). When cells respond poorly to insulin, the body produces more of it — and high insulin pushes the ovaries to make still more androgens. The loop tightens on itself.

And the "cysts"? Here is the reassuring part: they are usually not true cysts at all. They are small, immature follicles — eggs that began to develop but stalled because ovulation never completed. Understanding this takes much of the fear out of the word "polycystic."

How PCOS is actually diagnosed

Because PCOS/PCOD is a syndrome, no single blood test can confirm or rule it out. Doctors use the Rotterdam criteria, which require at least two of the following three features (Joham et al., The Lancet Diabetes & Endocrinology, 2022):

• Irregular or absent ovulation — irregular, infrequent, or missing periods.
• Signs of excess androgens — either clinical (acne, hirsutism, scalp hair thinning) or on a blood test.
• Polycystic ovarian morphology on ultrasound — many small follicles.

A few important nuances from the most recent guidance:

• The 2023 International Evidence-based Guideline — the most authoritative reference for PCOS worldwide — introduced a simplified diagnostic algorithm and now allows a blood marker called anti-Müllerian hormone (AMH) as an alternative to ultrasound in adults (Teede et al., 2023). That is genuinely useful in India, where a transvaginal scan is not always practical or culturally comfortable.
• The same guideline stresses that PCOS is far more than a fertility issue — it carries metabolic, cardiovascular, sleep, and psychological dimensions that all deserve attention (Teede et al., 2023).
• In adolescents, ultrasound is not used for diagnosis, because a teenager's ovaries normally show many follicles. Instead, both irregular cycles and signs of excess androgens are required (Joham et al., 2022).

This is precisely why a five-second label — "you have PCOD" — is not enough. A proper assessment means looking at your cycles, symptoms, hormones, and metabolic health together.

Why this matters so much for Indian women

PCOS is not rare here — it is strikingly common. A systematic review led by Indian researchers reported a pooled prevalence of around 21% across the studies it analysed, while worldwide estimates range from roughly 4% to 20% depending on the diagnostic criteria used (Deswal et al., Journal of Human Reproductive Sciences, 2020). On most reasonable estimates, something close to one in five Indian women of reproductive age is affected.

Two India-specific realities make the PCOD-versus-PCOS confusion more than academic:

• The "lean PCOS" trap. Insulin resistance and PCOS are not only conditions of higher body weight. Many slim Indian women carry significant metabolic dysfunction despite a "normal" BMI — and are wrongly reassured that they "can't have PCOS because they aren't overweight." They can, and frequently do.
• Diagnostic delay. When PCOD is dismissed as a minor inconvenience — "just take these pills, it will sort itself out after marriage or a baby" — the metabolic side, including insulin resistance and the long-term risk of type 2 diabetes and heart disease, goes unaddressed for years.

Naming the condition accurately, and taking its metabolic dimension seriously, is the first real step toward treating it well.

What actually helps — whatever you call it

Here is the genuinely hopeful part. Because the engine of PCOS/PCOD is largely metabolic, the most powerful first-line treatment is also the most accessible: nutrition and lifestyle.

A 2025 systematic review from researchers at the Indian Council of Medical Research (ICMR) and AIIMS, New Delhi, found that lifestyle changes — low–glycaemic-index eating, higher fibre, omega-3-rich foods, and regular physical activity — improve insulin sensitivity and hormonal balance and lower the long-term risk of metabolic and cardiovascular disease in women with PCOS (Gautam et al., Nutrients, 2025). International guidelines agree that a healthy lifestyle is the foundation, with medicines such as metformin, the combined oral contraceptive pill, or anti-androgens added when needed (Joham et al., 2022).

In an Indian household, that translates into practical, non-extreme steps:

• Build meals around protein and fibre first — dal, paneer, eggs, sprouts, vegetables — and treat refined carbs (white rice, maida, sugary chai, biscuits) as the side, not the centre of the plate.
• Don't eat carbohydrates "naked." Pair rice or roti with protein, vegetables, curd, or a healthy fat to soften the insulin spike.
• Move your body in ways you will actually repeat — a daily walk, some strength work, yoga. Consistency beats intensity.
• Protect your sleep and manage stress, because cortisol feeds the very same hormonal loop.

This is also where a careful, integrative Ayurvedic approach fits — not as a magic cure, but as personalised support for digestion, stress, and metabolic balance alongside evidence-based care. That is exactly the model our 90-day program is built around. If you are unsure which phenotype you have, or simply where to begin, the simplest next step is to speak with a practitioner who treats the whole picture rather than a single symptom: book a free first consultation with our team.

PCOD vs PCOS: the bottom line

• They are the same condition. PCOD is the older, ovary-focused term; PCOS is the medically precise, whole-system term used in global guidelines; PMOS is the emerging name that foregrounds metabolism.
• Neither word tells you how "serious" it is. Your phenotype and your insulin health do.
• The "cysts" are usually not cysts — they are stalled, immature follicles.
• Diagnosis needs more than an ultrasound — it rests on cycles, androgen signs, and metabolic health together.
• It is very common in India (roughly one in five women) and is frequently missed in lean women.
• The first-line treatment is nutrition and lifestyle, which are within your reach starting today.

When to see a doctor

Please seek a proper assessment if you notice any of the following: periods that are consistently irregular, very infrequent, or absent; troubling acne or unwanted hair growth; scalp hair thinning; difficulty conceiving after several months of trying; or a family history of diabetes alongside any of these signs. A correct diagnosis made early genuinely changes the long-term trajectory.

A note from me: the word your doctor used — PCOD, PCOS, or PMOS — matters far less than whether anyone has actually looked at your whole picture. You are not "just hormonal," and this is not your fault. With the right understanding and steady, realistic changes, this is one of the most manageable conditions I treat. — Dr. Megha

If you would like that whole-picture assessment, you can book a consultation here, or start by reading our explainer on understanding PMOS.

References

The following sources are peer-reviewed articles indexed on PubMed; each links to the PubMed record and the original article via its DOI.

• Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. Journal of Human Reproductive Sciences. 2020;13(4):261–271. PubMed — DOI
• Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. European Journal of Endocrinology. 2023;189(2):G43–G64. PubMed — DOI
• Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. The Lancet Diabetes & Endocrinology. 2022;10(9):668–680. PubMed — DOI
• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016;106(1):6–15. PubMed — DOI
• Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research. 2023;16(1):9. PubMed — DOI
• Gautam R, Maan P, Jyoti A, et al. The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients. 2025;17(2):310. PubMed — DOI

This article is for general education and is not a substitute for personalised medical advice. Please consult a qualified healthcare professional about your individual situation.